Skip to content

Magnetically Navigated vs. Manually Guided Radiofrequency in Atrioventricular-node-reentry-tachycardia

Randomized Comparison Between Magnetically Navigated vs Manually Guided Radiofrequency in AV-node-reentry-tachycardia

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00875914
Acronym
MAGMA-AVNRT
Enrollment
300
Registered
2009-04-06
Start date
2009-04-30
Completion date
2012-10-31
Last updated
2016-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrioventricular Nodal Reentry Tachycardia, Radiofrequency Ablation

Keywords

AV-node reentry tachycardia, radiofrequency ablation, magnetic navigation system

Brief summary

The MAGMA-AVNRT study compares two different methods of handling the ablation catheters for av-node-reentry-tachycardia with regard to x-ray dose, safety and success: manually guided vs magnetically navigated RF-catheter.

Detailed description

AV-node reentry tachycardia can be treated by radiofrequency ablation or modulation of the slow pathway of the av node. The success rate is 90 to 95%. There are different options to navigate the ablation catheter: manually guided vs magnetically guided. For magnetic guidance two magnets are positioned beneath the patient. A mangetic field is induced and a catheter with a ferromagnetic tip can be navigated from outside with a joystick by modifying the vectors of the magnetic field. We hypothesized that a magnetic guidance of the RF-ablation catheter results in lower x-ray time and dose for the patient and the physician with comparable safety und success rates.

Interventions

PROCEDURERF-ablation

4mm-tip catheter manually guided vs magneticallly navigated

Sponsors

University of Bergen
CollaboratorOTHER
Deutsches Herzzentrum Muenchen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* 18 to 70 years old * suspected AV-node-reentry-tachycardia * written informed consent

Exclusion criteria

* pregnancy * contraindication against electrophysiological study or ablation * congenital heart disease or other anatomical abnormalities * previous surgical procedure involving atrium except aorto-coronary bypass grafts * psychiatric disease that makes a completion of study improbable * severe comorbidities with a life expectancy less than 6 months

Design outcomes

Primary

MeasureTime frame
Total x-ray time and dose for patientelectrophysiological examination

Secondary

MeasureTime frame
X-ray time and dose for physicianelectrophysiological study
Safety of ablation (AV-Block, perforation)end of electrophysiological study
short-term and long-term-successend of procedure and 6 months after procedure
number of RF-applicationprocedure
Duration of electrophysiological study (ablation included)procedure

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026